Talcott Katherine E, Baxter Sally L, Chen Dinah K, Korot Edward, Lee Aaron, Kim Judy E, Modi Yasha, Moshfeghi Darius M, Singh Rishi P
Center for Ophthalmic Bioinformatics, Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Cleveland Clinic Lerner College of Medicine, Cleveland, OH, USA.
J Vitreoretin Dis. 2024 Apr 20;8(4):373-380. doi: 10.1177/24741264241247602. eCollection 2024 Jul-Aug.
Since the Artificial Intelligence Committee of the American Society of Retina Specialists developed the initial task force report in 2020, the artificial intelligence (AI) field has seen further adoption of US Food and Drug Administration-approved AI platforms and significant development of AI for various retinal conditions. With expansion of this technology comes further areas of challenges, including the data sources used in AI, the democracy of AI, commercialization, bias, and the need for provider education on the technology of AI. The overall focus of this committee report is to explore these recent issues as they relate to the continued development of AI and its integration into ophthalmology and retinal practice.
自美国视网膜专家协会人工智能委员会于2020年发布初始特别工作组报告以来,人工智能(AI)领域见证了美国食品药品监督管理局批准的人工智能平台得到进一步应用,以及针对各种视网膜疾病的人工智能技术取得重大进展。随着这项技术的扩展,随之而来的是更多挑战领域,包括人工智能所使用的数据来源、人工智能的普及性、商业化、偏差,以及临床医生接受人工智能技术培训的必要性。本委员会报告的总体重点是探讨这些与人工智能持续发展及其融入眼科和视网膜临床实践相关的最新问题。